New Atmosphere, New Vision: Gibson and Whittemore Kick Off Invest in ME Conference 2016
Mark Berry reports on Dr. Gibson's introduction and Dr. Whittemore's keynote speech, at the 11th Invest in ME International ME Conference in London.
Discuss the article on the Forums.

MND, ALS... HERVs... ARVs...

Discussion in 'Active Clinical Studies' started by merylg, Sep 28, 2016.

  1. merylg

    merylg Senior Member

    Messages:
    825
    Likes:
    639
    Sydney, NSW, Australia
  2. merylg

    merylg Senior Member

    Messages:
    825
    Likes:
    639
    Sydney, NSW, Australia
  3. ukxmrv

    ukxmrv Senior Member

    Messages:
    4,363
    Likes:
    4,477
    London
    "The Lighthouse Project is the first Phase 2 clinical trial in the world to use modern combination anti-retroviral therapy in patients with MND. The study aims to determine the safety and tolerability of an anti-retroviral therapy “Triumeq” and provide preliminary data on whether it is able to slow down the progression of MND. Triumeq is already used to treat HIV infection safely and effectively. "

    and

    "The Lighthouse Project is supported by the Motor Neurone Disease Research Institute of Australia and the Cure for MND Foundation."
     
    merylg likes this.

See more popular forum discussions.

Share This Page